Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Journal of Alzheimer'S Disease : JAD|April 29, 2017
A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD MiceHadar Segal-Gavish, Ortal Danino, Yael Barhum, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMIJames L Januzzi, C Michael Gibson, Gerald Chi, et al.
Journal of the American Heart Association|August 27, 2020
First Human Use of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point-of-Care Treatment of ST-Segment-Elevation Myocardial InfarctionDean J Kereiakes, Tim D Henry, Anthony N DeMaria, et al.
Human Mutation|February 8, 2006
Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3)Hava Peretz, Nurit Rosenberg, Meytal Landau, et al.
American Heart Journal|June 16, 2026
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMIJames L Januzzi, C Michael Gibson, Gerald Chi, et al.
Drug Design, Development and Therapy|January 23, 2015
Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activityTatjana Momic, Jehoshua Katzhendler, Ela Shai, et al.
Journal of Clinical and Translational Science|February 20, 2018
The Rockefeller University Clinical Scholars (KL2) Program 2006-2016Sarah J Schlesinger, Michelle Romanick, Jonathan N Tobin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2021
Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarctionWillem L Bor, Kai L Zheng, Anne H Tavenier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Pharmacotherapy|February 18, 2015
Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trialBruria Hirsh-Rokach, Galia Spectre, Ela Shai, et al.
Pageof 19